Cargando…
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
The antiphospholipid syndrome (APS) is characterized by recurrent fetal loss, vascular thrombosis, and thrombocytopenia occurring in the presence of antiphospholipid (aPL) antibodies. The pathogenesis of fetal loss and tissue injury in APS is incompletely understood, but is thought to involve platel...
Autores principales: | Holers, V. Michael, Girardi, Guillermina, Mo, Lian, Guthridge, Joel M., Molina, Hector, Pierangeli, Silvia S., Espinola, Ricardo, Xiaowei, Liu E., Mao, Dailing, Vialpando, Christopher G., Salmon, Jane E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193604/ https://www.ncbi.nlm.nih.gov/pubmed/11805148 http://dx.doi.org/10.1084/jem.200116116 |
Ejemplares similares
-
Antiphospholipid antibodies harness innate effectors, neutrophils and an alternative pathway of complement, to induce fetal damage
por: Salmon, J, et al.
Publicado: (2003) -
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction
por: Girardi, Guillermina, et al.
Publicado: (2006) -
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016) -
Inhibition of complement activation: a novel mechanism for the protective effects of heparin in antiphospholipid antibody-induced pregnancy loss
por: Girardi, G, et al.
Publicado: (2004) -
Pathophysiology of the antiphospholipid antibody syndrome
por: Willis, Rohan, et al.
Publicado: (2011)